| Fund ID | 805-5481089293 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | No |
| Sub-advised | No |
| % of assets independently valued | 9% |
| Owned by the adviser or related persons | 21% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 10% |
| Fund | Type | Gross assets |
|---|---|---|
| Mw Americas Tops Long-Only Fund LP | Hedge | $2.72B |
| Marshall Wace Investment Strategies - Tops US Equities Fund | Hedge | $1.82B |
| Marshall Wace Funds LP - Mw Tops US Equities (US) Fund | Hedge | $1.2B |
Mw Xo Health Innovations Fund, LP reports $230.9 million in gross assets, among the top 28% of private funds by size.
The stated minimum investment is $20 million.
Mw Xo Health Innovations Fund, LP is managed by Marshall Wace North America L.P.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.